Protective Effect of Topical Vitamin D3 against Photocarcinogenesis in a Murine Model.
Ann Dermatol. 2016 Jun;28(3):304-313. Epub 2016 May 25.
Kim JS1, Jung M1, Yoo J1, Choi EH2, Park BC1, Kim MH1, Hong SP1.
1Department of Dermatology, Dankook University College of Medicine, Cheonan, Korea.
2Department of Dermatology, Yonsei University Wonju College of Medicine, Wonju, Korea.
Wonder why they needed to use active vitamin D
See also VitaminDWiki
- Vitamin D protects DNA against UV skin damage – 5 studies 2012-2013
- 18X increased destruction of skin cancers if active vitamin D added to photodynamic therapy (mice) – March 2015
- Overview Suntan, melanoma and vitamin D
- Topical Vitamin D
The items in Skin Cancer and UV are listed here:
- Vitamin D from the sun reduces the risk of internal cancers, but increases some skin cancers – Nov 2021
- Book: Sunlight, UV, Vitamin D and Receptor, Skin and other Cancers - Dec 2020
- The Greatest Public Health Mistake of the 20th Century (sunscreen block Vitamin D) - 2017
- UVB improvements to Vitamin D receptor appear to improve melanoma survival – Oct 2017
- UVA causes skin cancer, perhaps UVB (Vitamin D) prevents skin cancer – Jan 2017
- Skin cancer (in mice) due to UV was prevented by vitamin D (active, topical) – June 2016
- UV – adverse and beneficial effects – review Nov 2014
- UV Radiation and the Skin June 2013
- Vitamin D protects mouse from skin cancer – Sept 2012
- Vitamin D protects DNA against UV skin damage – 5 studies 2012-2013
- Too much UVB: skin cancer, too little UVB: other cancers due to low vitamin D – April 2012
- Use of tanning beds would reduce associated deaths by 10X – Oct 2011
- Hypothesis: UVA through window glass decreases vitamin D - 2009
- Most sunscreens actually increase the growth of skin cancer - May 2010
Download the PDF from VitaminDWiki
BACKGROUND:
Although the incidence of non-melanoma skin cancer is increasing, there are no effective practical preventive measures other than avoiding sun exposure.
OBJECTIVE:
To elucidate the protective effect of topical application of biologically active vitamin D3 (calcitriol) on skin cancer development caused by exposure to ultraviolet (UV).
METHODS:
Groups of hairless mice were topically treated with either calcitriol or vehicle immediately after exposure to UVB and UVA three times weekly for the initial 20 weeks, and without UV exposure in the following 6 weeks. Tumor number was counted and biopsies were done for histopathologic analysis. The changes of cyclobutane pyrimidine dimer (CPD) were evaluated 1 hour and 11 hours after short term of UV exposure and application of calcitriol. For safety evaluation, blood test and body weights were evaluated at 23rd and 25th week.
RESULTS:
Total tumor count and number of tumors less than 3 mm in size tended to be fewer in calcitriol group, and tumors more than 3 mm in size showed significantly lower tumor formation rate in calcitriol group. Single application of calcitriol reduced CPD at 1 hour and 11 hours after UV exposure. Histopathologic analysis showed tumors with lower grade malignancy in calcitriol group which suggested a delay in tumor progression. However, serum levels of calcium and phosphate in calcitriol group were above normal range, and weight loss was found.
CONCLUSION:
Topical calcitriol may suppress the formation and progression of UV-induced non-melanoma skin cancer by enhancing the repair mechanism of UV damage.
PMID: 27274628